Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: CD as API

March 2, 2026 CD as API / Pharma applications

Beren Therapeutics’Adrabetadex Received FDA Acceptance for infantile-onset Niemann Pick Disease

Beren Therapeutics Announced FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann-Pick Disease Type C. Beren Therapeutics

Continue reading

February 23, 2026 CD as API / Pharma applications

The mechanism of ototoxicity studied by using HPBCD

The cochlea is the sensory organ responsible for hearing. Central to its sensory functions is the organ of Corti, a

Continue reading

February 19, 2026 CD as API / Drug delivery / Pharma applications

Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-Cyclodextrin

Previous studies have demonstrated that the solubility and biocompatibility of poorly water-soluble anti-cancer agents can be improved by complexation with

Continue reading

February 9, 2026 CD as API / Drug delivery / Pharma applications

CDs for Regulating Cholesterol Homeostasis in Atherosclerosis

The progression of atherosclerosis (AS) is strongly linked to lipid crystals accumulation caused by cholesterol metabolism disorders and the worsening

Continue reading

February 4, 2026 CD as API / CD derivatives / Pharma applications

Studies on Sleep-Deprived Animals Reveal HPBCD’s Role in Restoring Normal Neuronal Function

A study published in Proceedings of the National Academy of Sciences (https://www.pnas.org/doi/10.1073/pnas.2523438123) suggests that lack of sleep harms the fatty insulation that

Continue reading

January 27, 2026 CD as API / Pharma applications

A water-soluble β-cyclodextrin polymer reduces cholesterol accumulation and autophagy dysfunction in vitro and in Niemann-Pick type C disease model mice

A β-CDP (CycloLab) was used for the experiments. The purity of the β-CDP was >95 %. The β-CDP contained <1 % of

Continue reading

January 19, 2026 CD as API / Pharma applications

Sugammadex vs. Neostigmine Reversal After Thoracoscopic Thymectomy in Myasthenia Gravis

Rapid and complete reversal of residual neuromuscular blockade (rNMB) is essential for safe postoperative recovery in patients with myasthenia gravis

Continue reading

January 12, 2026 CD as API / CD derivatives / Drug delivery / Non-pharma applications / Pharma applications / Uncategorized

Special Issue of the 21st International Cyclodextrin Symposium

The papers from the Special Issue of the 21st International Cyclodextrin Symposium published in Carbohydrate Polymers are available (https://www.sciencedirect.com/special-issue/10BLTS8S758).  The

Continue reading

January 9, 2026 CD as API / Pharma applications

Hydroxypropyl-Beta-Cyclodextrin (HPBCD) inhibits SARS-CoV-2 replication by modulating intracellular lipid dynamics

A multi-year scientific collaboration between Brasilian and American scientists from Federal University at Rio de Janeiro, Brazil, Laboratory of Immunoregulation,

Continue reading

January 6, 2026 CD as API / CD derivatives / Pharma applications

Sulfonated, sulfated thioglycosides and multivalence in heparanase inhibition

Heparan sulfate (HS) analogs are synthetic oligo- and polysaccharides designed to mimic or enhance several biological properties of native HS.

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 … 35 Next Posts»

Recent Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • 2 nd International Conference on Biomedical Science and Engineering
  • Sugammadex vs Neostigmine: Effects on Obese Patients’ Recovery
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin complexation of selected tyrosine kinase inhibitors

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (343)
  • CD derivatives (404)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (784)
  • E-ducation (63)
  • Environmental (132)
  • Events (233)
  • Food (219)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (396)
  • Other industrial use (104)
  • Pharma applications (1,172)
  • Supramolecular systems (40)
  • Uncategorized (143)

Top Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin-in-Liposome for therapy: Advances and challenges
  • Pilocarpine eye drops (Vuity)
  • Lanosterol eye drops for cataract treatment
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy
  • CDs for the removal of PFAS; A review
  • Cyclodextrins Meet Cosmetics, a review
  • Appropriate Dosing of Sugammadex in Morbidly Obese Patients
  • Water-Soluble EDTA-Crosslinked Poly-β-Cyclodextrins as Ion-Complexing Drug Carriers.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers

Loading Comments...